Msh3 forms heterodimers with Msh2 to create the MutSβ complex, which recognizes insertion-deletion loops (IDLs) and larger mismatches during DNA replication. Key functions include:
Mismatch Recognition: Binds to DNA mismatches and recruits MutL homologs (e.g., Mlh1-Pms1) to initiate repair .
ATPase Activity: Hydrolyzes ATP to facilitate conformational changes required for repair .
Homologous Recombination: Assists in double-strand break repair via interactions with recombination mediators .
In Aspergillus niger, Msh3’s partial recombinant form retains these functionalities in vitro, enabling studies on fungal DNA repair pathways .
Mutation Frequency: Deletion of msh3 in Aspergillus fumigatus increases mutation rates under oxidative stress, accelerating resistance to antifungals like voriconazole .
DNA Damage Response: Msh3-deficient strains exhibit impaired repair of DNA lesions caused by alkylating agents, highlighting its role in maintaining genomic stability .
Protein Engineering: Recombinant Msh3 variants are used to study fungal adaptation mechanisms under environmental stress .
Drug Development: Targeting Msh3’s ATPase domain could enhance antifungal efficacy by destabilizing DNA repair in pathogens .
| Feature | Aspergillus niger Msh3 | Human MSH3 | Saccharomyces cerevisiae Msh3 |
|---|---|---|---|
| Primary Role | MMR, antifungal resistance | MMR, EMAST suppression | MMR, meiotic recombination |
| Key Domains | Walker A, FLY motifs | NLS1, NES1/2 | Transmitter region |
| Pathway Specificity | Fungal MMR | Nuclear-cytosolic shuttling | MMR and 3’NHTR |
| Mutation Impact | ↑ Antifungal resistance | ↑ Colorectal cancer risk | ↑ Microsatellite instability |
Functional Redundancy: Overlapping roles with Msh6 complicate mechanistic studies in fungal MMR .
Structural Dynamics: Full-length protein expression is needed to resolve conformational changes during ATP hydrolysis .
Clinical Relevance: Polymorphisms near nuclear localization signals (e.g., Δ27bp in humans) could inform fungal Msh3 engineering .
STRING: 5061.CADANGAP00010428
MSH3 in Aspergillus species functions as an essential component of the highly conserved DNA mismatch repair (MMR) system that maintains genomic stability. In eukaryotes, including fungi, repair is initiated by heterodimeric MutS homolog (Msh) complexes that form sliding clamps on DNA to scan for nucleotide misincorporation events and extrahelical lesions introduced during DNA replication and homologous recombination . Specifically, MSH3 partners with MSH2 to form the MutSβ heteroduplex that primarily recognizes insertion-deletion loops (IDLs) involving one or more unpaired nucleotides and some single-nucleotide mismatches . After lesion recognition, MutL homolog (Mlh) complexes are recruited to the repair site, where they harbor a mismatch-dependent endonuclease activity critical for MMR . This process is followed by exonuclease activity and DNA synthesis to complete the repair.
While the specific structure of A. niger MSH3 has not been completely characterized, comparative analysis with well-studied homologs provides significant insights. Based on human MSH3 data, the protein likely contains conserved DNA binding domains, ATPase domains, and protein interaction regions essential for forming the heterodimer with MSH2 . The human MSH3 protein has a calculated molecular weight of approximately 40.3 kDa and forms a functional MutSβ complex that initiates mismatch repair by binding to a mismatch before forming a complex with MutLα heterodimer . In Aspergillus fumigatus, the MSH2 homolog (mshA) shows significant variation among strains, with 12 strains out of 62 (18.2%) exhibiting variants, suggesting that similar structural diversity might exist in A. niger MSH3 . This structural diversity could contribute to functional differences in repair efficiency and potentially impact phenotypes like antifungal resistance.
Research in various organisms demonstrates MSH3's critical role in genomic stability. In colorectal cancer studies, MSH3-deficient cells show increased sensitivity to the irinotecan metabolite SN-38 and to oxaliplatin, indicating its role in responding to specific types of DNA damage . These MSH3-deficient cells exhibit higher levels of phosphorylated histone H2AX and Chk2, markers of DNA damage response activation . Additionally, studies in A. fumigatus revealed that mshA null mutants (MSH2 homolog) could influence virulence in both neutropenic murine models of invasive pulmonary aspergillosis and in the moth Galleria mellonella . These findings collectively suggest that MSH3 in A. niger likely plays a similar crucial role in maintaining genomic integrity and may influence pathogenicity and stress responses.
For optimal expression of recombinant A. niger MSH3, multiple expression systems should be considered based on experimental requirements:
| Expression System | Advantages | Limitations | Recommended For |
|---|---|---|---|
| E. coli (BL21 DE3) | High yield, simple protocol, cost-effective | Potential inclusion body formation, limited post-translational modifications | Initial characterization studies, structural analysis |
| Yeast (P. pastoris) | Better folding for eukaryotic proteins, secretion possible | Lower yields than E. coli, longer expression time | Functional studies requiring proper folding |
| Insect cells (Baculovirus) | Excellent for complex eukaryotic proteins, proper folding | Expensive, technically demanding | Detailed enzymatic studies, interaction analyses |
| Cell-free systems | Rapid, avoids toxicity issues | Lower yield, expensive | Difficult-to-express variants, toxic proteins |
For E. coli expression systems, fusion tags like His-tag can facilitate purification, as demonstrated with human MSH3 recombinant protein . Expression at lower temperatures (16-18°C) after induction can improve solubility. Based on protocols for similar recombinant proteins, the pET expression system combined with a His-tag for purification represents a good starting point .
A multi-step purification strategy is essential for obtaining high-purity, functional recombinant A. niger MSH3:
Initial capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA resin for His-tagged protein, with optimized imidazole gradients to minimize non-specific binding .
Intermediate purification: Ion exchange chromatography (typically anion exchange at pH 8.0) to separate based on charge differences and remove nucleic acid contamination.
Polishing step: Size exclusion chromatography to achieve final purity and confirm proper oligomeric state.
Buffer optimization: Final buffer composition significantly impacts stability - typically 20-50 mM Tris-HCl pH 7.5-8.0, 100-200 mM NaCl, 1-5 mM DTT or 0.5-1 mM TCEP, and 5-10% glycerol for storage.
For human MSH3 recombinant protein, lyophilization from sterile PBS (pH 7.4) with 5% trehalose, 5% mannitol, and 0.25M Arginine has proven effective for storage stability . Regular quality control testing should include SDS-PAGE, western blotting, and functional DNA binding assays to confirm protein integrity.
Functional validation of purified recombinant A. niger MSH3 requires multiple complementary approaches:
| Assay Type | Methodology | Measures | Controls Required |
|---|---|---|---|
| DNA Binding | EMSA (Electrophoretic Mobility Shift Assay) | Ability to bind mismatched DNA | Homoduplex DNA, competitor DNA |
| ATPase Activity | Malachite green phosphate detection | ATP hydrolysis rate | No DNA control, non-hydrolyzable ATP analog |
| Protein-Protein Interaction | Pull-down assay with MSH2 | Complex formation | GST-only control, non-specific protein |
| Conformational Integrity | Circular dichroism, thermal shift | Proper folding, stability | Denatured protein control |
| Functional MMR | In vitro mismatch repair reconstitution | Complete repair function | Single component omission controls |
When studying MSH3-DNA interactions, researchers should use DNA substrates containing specific mismatches or insertion-deletion loops (IDLs) . It's also crucial to test MSH3 in complex with MSH2 to form the functional MutSβ complex for complete activity assessment, as MSH3 forms a heterodimer with MSH2 to initiate mismatch repair .
Research with A. fumigatus provides compelling evidence that mismatch repair proteins like MSH3 can significantly impact antifungal resistance development. Studies demonstrated that loss of mshA (the MSH2 homolog) function can provide increased azole resistance when selected for . The mechanism likely involves increased genomic instability and mutation rates in the absence of proper mismatch repair, accelerating the development of resistance-conferring mutations.
To investigate MSH3's role in A. niger antifungal resistance, researchers should:
Generate MSH3 knockout or knockdown strains using CRISPR-Cas9 or RNAi techniques
Perform susceptibility testing against multiple antifungal classes (azoles, echinocandins, polyenes)
Conduct evolution experiments with sub-inhibitory antifungal concentrations
Analyze mutation spectra and rates in wild-type versus MSH3-deficient strains
Sequence resistant isolates to identify resistance-conferring mutations
The finding that A. fumigatus mshA null mutants demonstrated enhanced virulence attributes after sequential mitotic passages suggests that similar phenotypic evolution might occur with A. niger MSH3 mutants .
The connection between mismatch repair deficiency and virulence has been established in A. fumigatus, where researchers demonstrated that mshA null mutants influenced virulence in both a neutropenic murine model of invasive pulmonary aspergillosis and in the moth Galleria mellonella . Different populations of the null mshA mutants grown through 10 sequential mitotic passages evolved virulence attributes in the G. mellonella model of infection .
For A. niger MSH3, researchers investigating its role in virulence should consider:
Creating targeted MSH3 gene deletions or mutations
Evaluating phenotypic changes in stress resistance (oxidative, pH, temperature)
Assessing adhesion to host cells and tissues
Measuring secretion of hydrolytic enzymes and secondary metabolites
Conducting in vivo virulence studies in appropriate animal models
The hypermutator phenotype typically associated with mismatch repair deficiency may allow more rapid adaptation to host environments, potentially enhancing virulence through accelerated evolution.
Site-directed mutagenesis represents a powerful approach to dissect the functional domains of A. niger MSH3. Based on conserved domains in homologous proteins, researchers should target:
| Domain | Target Residues | Expected Effect | Validation Method |
|---|---|---|---|
| DNA Binding | Conserved positively charged residues | Reduced mismatch recognition | EMSA, SPR with mismatched DNA |
| ATPase | Walker A/B motifs | Impaired ATP hydrolysis | ATPase activity assay |
| MSH2 Interaction | Interface residues | Disrupted complex formation | Co-immunoprecipitation, gel filtration |
| Conformational change | Hinge region residues | Altered mismatch-induced signaling | FRET-based conformational assays |
When designing mutagenesis experiments, researchers should refer to the amino acid sequence of homologous proteins like human MSH3, which has been well-characterized . Single amino acid substitutions can provide insights into critical residues, while domain swapping or deletion constructs can reveal the function of larger protein regions. The systematic mutational analysis should progress from conserved motifs to less conserved regions to build a comprehensive structure-function map.
Several complementary techniques can effectively characterize MSH3-DNA interactions:
| Technique | Information Provided | Advantages | Limitations |
|---|---|---|---|
| EMSA | Qualitative binding | Simple, widely accessible | Semi-quantitative only |
| SPR | Kinetics, affinity constants | Real-time measurements, no labels | Requires specialized equipment |
| Fluorescence Anisotropy | Solution-phase binding | Equilibrium measurements | Requires fluorescent labeling |
| DNA Footprinting | Base-specific contacts | High resolution of binding site | Labor intensive |
| Single-molecule FRET | Dynamic conformational changes | Real-time single-molecule resolution | Complex setup, specialized expertise |
For initial characterization, EMSA using fluorescently labeled oligonucleotides containing specific mismatches or IDLs provides a straightforward approach . For quantitative studies, SPR or fluorescence anisotropy can determine binding constants. To reconstitute the complete mismatch recognition process, it's crucial to include both MSH3 and MSH2 to form the functional MutSβ complex, as MSH3 forms a heterodimer with MSH2 to initiate mismatch repair .
Common challenges in recombinant MSH3 production and their solutions include:
Poor expression levels:
Optimize codon usage for the expression host
Try different promoters (T7, tac, AOX1)
Adjust induction conditions (temperature, inducer concentration)
Consider autoinduction media for E. coli expression
Protein insolubility:
Lower expression temperature (16-18°C)
Use solubility-enhancing tags (MBP, SUMO, TrxA)
Add solubility enhancers to lysis buffer (0.1% Triton X-100, 5-10% glycerol)
Try co-expression with MSH2 partner
Degradation during purification:
Include protease inhibitor cocktail
Maintain samples at 4°C throughout purification
Minimize purification time with optimized protocols
Add stabilizing agents (ATP, ADP, DNA oligonucleotides)
Loss of activity:
Verify proper folding by circular dichroism
Optimize buffer conditions with thermal shift assays
Test different storage conditions (glycerol percentage, flash freezing vs. slow cooling)
Consider storage with stabilizing ligands
For MSH3 specifically, the formation of a complex with MSH2 is critical for its natural function and may enhance stability . Purification protocols similar to those used for human recombinant MSH3 protein, which include lyophilization from sterile PBS with stabilizing agents like trehalose and mannitol, may be adapted for A. niger MSH3 .
To comprehensively investigate A. niger MSH3's role in genomic stability, a multi-faceted experimental approach is required:
Mutation rate analysis:
Fluctuation analysis to determine spontaneous mutation rates
Specific reporter systems for different mutation types (point mutations, insertions/deletions)
Whole-genome sequencing to determine mutation spectra
DNA damage response:
Sensitivity assays to different DNA-damaging agents
Immunofluorescence for DNA damage markers (γH2AX)
Analysis of checkpoint activation (Chk1/Chk2 phosphorylation)
Genetic interaction studies:
Double mutant analysis with other DNA repair pathways
Synthetic genetic arrays to identify functionally related genes
High-throughput drug sensitivity profiling
In vitro reconstitution:
Biochemical assays with purified components
Single-molecule approaches to study repair dynamics
Structure determination of protein-DNA complexes
When designing these experiments, appropriate controls are essential. For knockout studies, complementation with wild-type MSH3 should restore normal phenotypes. Time-course studies can reveal the kinetics of mutation accumulation in MSH3-deficient strains. Comparative analysis with MSH3 mutants from other fungal species, such as the well-studied A. fumigatus mshA mutants that showed increased azole resistance and virulence, can provide valuable context .
CRISPR-Cas9 technology offers revolutionary approaches for studying A. niger MSH3 function:
Precise genome editing:
Introduction of specific point mutations at endogenous locus
Domain deletions or swaps to assess functional regions
Tagged versions for localization and interaction studies
High-throughput functional screening:
CRISPR interference (CRISPRi) for conditional knockdown
CRISPR activation (CRISPRa) for overexpression studies
CRISPR-Cas9 screens with guide RNA libraries for genetic interactions
Mechanistic studies:
CRISPR base editors for introducing specific mismatches
CRISPR-X for targeted mutagenesis of specific genomic regions
CRISPR-mediated fluorescent tagging for live-cell imaging
For A. niger specifically, optimization of CRISPR-Cas9 protocols should focus on efficient transformation methods, appropriate promoters for guide RNA and Cas9 expression, and careful selection of target sites to minimize off-target effects.
Comparative genomics can provide insights into MSH3 evolution and function across fungal species:
Phylogenetic analysis:
Construct phylogenetic trees of MSH3 across diverse fungi
Identify lineage-specific adaptations and selection pressures
Correlate MSH3 sequence variations with ecological niches
Structural comparisons:
Identify conserved domains and critical residues
Model species-specific structural differences
Predict functional differences based on structural variations
Population genomics:
Analyze natural variation in MSH3 within A. niger populations
Identify potential adaptive mutations
Correlate genotypic variation with phenotypic differences
The observation that 18.2% of A. fumigatus strains examined showed variants in the mshA gene suggests significant natural variation might also exist in A. niger MSH3 . This variation could contribute to differences in mutation rates, DNA repair efficiency, and potentially antifungal susceptibility among different strains.